UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-23 6:56 pm Sale | 2021-09-22 | 13G | Taysha Gene Therapies, Inc. TSHA | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,156,255 3.010% | -1,022,745 (-46.94%) | Filing |
| 2021-02-16 1:35 pm Purchase | 2020-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 2,179,000 5.770% | 2,179,000 (New Position) | Filing |
| 2021-02-03 6:14 pm Purchase | 2020-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 2,179,000 5.770% | 2,179,000 (New Position) | Filing |